Skip to search formSkip to main contentSkip to account menu

Graft versus host disease prophylaxis/therapy

Known as: prophylaxis/therapy, graft versus host disease, prophylaxis/therapy, GVHD, GVHD 
Therapy to prevent or treat graft vs host disease.
National Institutes of Health

Related topics

Related topics

3 relations
Biological Response Modifier TherapyGraft-vs-Host DiseaseSupportive care

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect
We report a series of 37 consecutive patients with multiple myeloma (MM) who received an allograft between 1990 and 2000 at our… 
Review
1998
Review
1998
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group…
The best treatment of CMV gastrointestinal disease has been controversial, with some centers adding intravenous (i.v.) Ig to… 
1994
1994
Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers.
Graft-versus-host disease (GVHD) occurring after liver transplantation can pose a difficult diagnostic dilemma. Similar clinical… 
Highly Cited
1993
Highly Cited
1993
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction
The aim of this study was to evaluate levels and subclass distribution of pneumococcal antibodies in 40 bone marrow transplant… 
Highly Cited
1989
Highly Cited
1989
Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.
Thirty-two children ranging in age from 1.5 to 16 years with poor-prognosis acute lymphoblastic leukemia (ALL) were treated with… 
Highly Cited
1987
Highly Cited
1987
The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice
A quantitative analysis of the frequencies of autoantibody-producing B cells in GVHD and in normal mice has been undertaken by… 
Highly Cited
1986
Highly Cited
1986
Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes…
Cutaneous graft-versus-host disease (GVHD) provides a unique model for studying the pathogenesis of several important lymphocyte… 
Highly Cited
1984
Highly Cited
1984
Study of Langerhans cells after allogeneic bone marrow transplantation.
We assessed the number of Langerhans cells (LC) before and after bone marrow transplantation (BMT) in 27 patients in order to… 
1984
1984
Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
The pathologic symptoms in F1 mice with chronic graft-vs-host disease (GVHD) (GVH F1) strongly resemble those of systemic lupus… 
Review
1983
Review
1983
Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
In a double-blind controlled study, oral acyclovir has been compared to a placebo in a series of 39 consecutive patients…